Brii Biosciences Limited (7SS) Financial Statements
Brii Biosciences Limited Financial Overview
Brii Biosciences Limited's market cap is currently $80.60M. The company's EPS TTM is $-0.24; its P/E ratio is -3.48; Brii Biosciences Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 18.12M | $ 54.29M | $ 56.32M | $ 51.63M | $ 92.54M |
| Gross Profit | $ 0.00 | $ 54.29M | $ 56.32M | $ 51.63M | $ 92.54M |
| Operating Income | $ -295.88M | $ -399.50M | $ -544.30M | $ -513.85M | $ -610.48M |
| EBITDA | $ -290.29M | $ -390.65M | $ -168.20M | $ -496.81M | $ -593.22M |
| Net Income | $ -216.86M | $ -508.16M | $ -174.83M | $ -484.31M | $ -4.12B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.94B | $ 2.33B | $ 2.66B | $ 3.00B | $ 3.35B |
| Total Assets | $ 2.36B | $ 2.71B | $ 3.20B | $ 3.39B | $ 3.61B |
| Total Debt | $ 8.93M | $ 28.02M | $ 3.16M | $ 12.66M | $ 21.62M |
| Net Debt | $ -599.70M | $ -975.35M | $ -486.49M | $ -1.18B | $ -2.83B |
| Total Liabilities | $ 36.22M | $ 100.55M | $ 125.87M | $ 234.35M | $ 300.44M |
| Stockholders' Equity | $ 2.38B | $ 2.66B | $ 3.12B | $ 3.19B | $ 3.34B |
| Cash Flow | |||||
| Free Cash Flow | $ -288.42M | $ -376.12M | $ -643.62M | $ -635.57M | $ -880.49M |
| Operating Cash Flow | $ -286.55M | $ -372.89M | $ -594.01M | $ -496.28M | $ -879.46M |
| Investing Cash Flow | $ -151.31M | $ 895.47M | $ -104.35M | $ -1.43B | $ -475.76M |
| Financing Cash Flow | $ -39.12M | $ -9.41M | $ -10.98M | $ -3.04M | $ 3.23B |
Currency in CNY